These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21359727)

  • 1. Comparative pharmacokinetics of antisense oligonucleotides.
    Agrawal S; Temsamani J
    Methods Mol Med; 1996; 1():247-70. PubMed ID: 21359727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi: a novel antisense technology and its therapeutic potential.
    Dallas A; Vlassov AV
    Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
    Delihas N; Rokita SE; Zheng P
    Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospects for antisense therapy].
    Maekawa T
    Rinsho Ketsueki; 1995 May; 36(5):410-8. PubMed ID: 7783344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of ENA gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression.
    Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2006; (50):319-20. PubMed ID: 17150946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antisense oligonucleotide inhibition of coxsackievirus B3 gene expression in HeLa cells and dose-response experiments].
    Liu ZW; Sun HM; Xiao ZH; Qiu N; Zhang T; Zhao JM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):62-5. PubMed ID: 15340530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides: from design to therapeutic application.
    Chan JH; Lim S; Wong WS
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):533-40. PubMed ID: 16700890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and therapeutic oligonucleotides.
    Hartmann G; Bidlingmaier M; Eigler A; Hacker U; Endres S
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):247-56. PubMed ID: 9740353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Toll-like receptors in antisense and siRNA [corrected].
    Agrawal S; Kandimalla ER
    Nat Biotechnol; 2004 Dec; 22(12):1533-7. PubMed ID: 15583662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
    Jen KY; Gewirtz AM
    Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
    Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
    J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo pharmacologic activities of antisense oligonucleotides.
    Mirabelli CK; Bennett CF; Anderson K; Crooke ST
    Anticancer Drug Des; 1991 Dec; 6(6):647-61. PubMed ID: 1663361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines.
    Michel S; Schirduan K; Shen Y; Klar R; Tost J; Jaschinski F
    Mol Diagn Ther; 2021 Jan; 25(1):77-85. PubMed ID: 33314011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of sequences in rotavirus mRNAs important for minus strand synthesis using antisense oligonucleotides.
    Barro M; Mandiola P; Chen D; Patton JT; Spencer E
    Virology; 2001 Sep; 288(1):71-80. PubMed ID: 11543659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.